MA52352A - Macrocycles peptidiques contre acinetobacter baumannii - Google Patents
Macrocycles peptidiques contre acinetobacter baumanniiInfo
- Publication number
- MA52352A MA52352A MA052352A MA52352A MA52352A MA 52352 A MA52352 A MA 52352A MA 052352 A MA052352 A MA 052352A MA 52352 A MA52352 A MA 52352A MA 52352 A MA52352 A MA 52352A
- Authority
- MA
- Morocco
- Prior art keywords
- peptidic
- acinetobacter baumannii
- against acinetobacter
- macrocycles
- macrocycles against
- Prior art date
Links
- 241000588626 Acinetobacter baumannii Species 0.000 title 1
- 150000002678 macrocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Analytical Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNPCT/CN2018/084131 | 2018-04-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA52352A true MA52352A (fr) | 2021-03-03 |
Family
ID=66290410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA052352A MA52352A (fr) | 2018-04-23 | 2019-04-23 | Macrocycles peptidiques contre acinetobacter baumannii |
Country Status (20)
Country | Link |
---|---|
US (2) | US11819532B2 (fr) |
EP (1) | EP3784262A1 (fr) |
JP (2) | JP7460541B2 (fr) |
KR (1) | KR20210005574A (fr) |
CN (1) | CN111886020B (fr) |
AR (1) | AR114290A1 (fr) |
AU (1) | AU2019260124A1 (fr) |
BR (1) | BR112020021729A2 (fr) |
CA (1) | CA3089688A1 (fr) |
CL (1) | CL2020002695A1 (fr) |
CR (1) | CR20200488A (fr) |
IL (2) | IL309537A (fr) |
MA (1) | MA52352A (fr) |
MX (1) | MX2020007633A (fr) |
PE (1) | PE20210855A1 (fr) |
PH (1) | PH12020551762A1 (fr) |
SG (1) | SG11202007219PA (fr) |
TW (1) | TWI833748B (fr) |
UA (1) | UA126943C2 (fr) |
WO (1) | WO2019206853A1 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3368544T3 (da) | 2015-10-27 | 2020-08-24 | Hoffmann La Roche | Peptidmakrocykler mod Acinetobacter baumannii |
US11505573B2 (en) | 2018-03-28 | 2022-11-22 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
US11819532B2 (en) * | 2018-04-23 | 2023-11-21 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
PL3784663T3 (pl) | 2018-04-23 | 2023-12-27 | Celgene Corporation | Podstawione związki 4-aminoizoindolino-1,3-dionowe i ich zastosowanie do leczenia chłoniaka |
TW202100522A (zh) | 2019-03-08 | 2021-01-01 | 瑞士商赫孚孟拉羅股份公司 | 新穎咪唑-吡唑衍生物 |
CN114981259B (zh) | 2020-01-22 | 2024-06-18 | 豪夫迈·罗氏有限公司 | 新型杂环化合物 |
EP4143190A1 (fr) | 2020-04-29 | 2023-03-08 | F. Hoffmann-La Roche AG | Dérivés antibactériens de 8-phénylamino-3-(pyrazol-4-yl)imidazo[1,2-a]pyrazine |
JP2023527479A (ja) | 2020-06-01 | 2023-06-28 | エフ. ホフマン-ラ ロシュ アーゲー | 新規イミダゾピラジン誘導体 |
JP2023529578A (ja) | 2020-06-08 | 2023-07-11 | エフ. ホフマン-ラ ロシュ アーゲー | 新規イミダゾ-ピラジン誘導体 |
CN115916784A (zh) | 2020-06-09 | 2023-04-04 | 豪夫迈·罗氏有限公司 | 新型咪唑并吡嗪衍生物 |
WO2022043486A1 (fr) | 2020-08-31 | 2022-03-03 | F. Hoffmann-La Roche Ag | Dérivés d'imidazole-pyrazole utilisés en tant qu'antibactériens |
CN115989227A (zh) | 2020-09-01 | 2023-04-18 | 豪夫迈·罗氏有限公司 | 具有抗菌性的咪唑-吡唑衍生物 |
JP2023539782A (ja) | 2020-09-07 | 2023-09-19 | エフ. ホフマン-ラ ロシュ アーゲー | 新規複素環式抗生物質 |
JP2024506021A (ja) | 2021-02-07 | 2024-02-08 | エフ. ホフマン-ラ ロシュ アーゲー | 新規ヘテロアリール置換イミダゾール誘導体 |
EP4367102A1 (fr) | 2021-07-06 | 2024-05-15 | F. Hoffmann-La Roche AG | Composés à substitution par cations ammonium quaternaires pour le traitement d'infections bactériennes |
CN118119609A (zh) | 2021-07-15 | 2024-05-31 | 豪夫迈·罗氏有限公司 | 咪唑衍生物及其作为抗生素的用途 |
CA3237617A1 (fr) * | 2022-02-14 | 2023-08-17 | F. Hoffmann-La Roche Ag | Procede de fabrication de peptides macrocycliques |
CN118632842A (zh) | 2022-02-25 | 2024-09-10 | 豪夫迈·罗氏有限公司 | 两性离子抗细菌化合物 |
WO2023194418A1 (fr) | 2022-04-07 | 2023-10-12 | F. Hoffmann-La Roche Ag | Formes cristallines d'un antibiotique peptidique macrocyclique |
WO2024033278A1 (fr) | 2022-08-09 | 2024-02-15 | F. Hoffmann-La Roche Ag | Procédé de fabrication d'un peptide macrocyclique antibiotique |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6660832B1 (en) | 1999-08-20 | 2003-12-09 | Isis Pharmaceuticals, Inc. | Macrocyclic compounds and preparation methods thereof |
DE10226921A1 (de) | 2002-06-17 | 2003-12-24 | Bayer Ag | Antibakterielle Amid-Makrozyklen |
DE10234422A1 (de) | 2002-07-29 | 2004-02-12 | Bayer Ag | Antibakterielle Ester-Makrozyklen |
EP1506203B1 (fr) | 2002-08-23 | 2007-01-03 | Sloan-Kettering Institute For Cancer Research | Synthese d'epothilones, leurs intermediaires, leurs analogues et leurs utilisations |
EP1633774B1 (fr) | 2003-06-18 | 2010-02-17 | Tranzyme Pharma Inc. | Antagonistes macrocycliques du recepteur de motiline |
US7491695B2 (en) | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
EP1498422A1 (fr) | 2003-07-17 | 2005-01-19 | Jerini AG | Antagonistes du Recepteur C5a |
DE602004018782D1 (de) | 2003-07-31 | 2009-02-12 | Tranzyme Pharma Inc | Räumlich definierte makrocyclen, die peptidbindungssurrogate enthalten |
SI1648922T1 (sl) | 2003-07-31 | 2011-03-31 | Tranzyme Pharma Inc | Prostorsko opredeljene makrocikliäśne spojine uporabne za odkrivanje zdravil |
JP2008502583A (ja) | 2003-10-01 | 2008-01-31 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 抗細菌性アミド大員環 |
EP1737884B1 (fr) | 2004-03-19 | 2016-10-19 | The University Of Queensland | Alpha-mimetiques helicoidales, leurs utilisations et leurs procedes de production |
DE102004025731A1 (de) | 2004-05-26 | 2005-12-15 | Bayer Healthcare Ag | Antibakterielle Amid-Makrozyklen III |
US20060004185A1 (en) | 2004-07-01 | 2006-01-05 | Leese Richard A | Peptide antibiotics and peptide intermediates for their prepartion |
CN101107264A (zh) | 2005-01-17 | 2008-01-16 | 捷瑞尼股份公司 | C5a受体拮抗剂 |
DE102005014245A1 (de) | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Antibakterielle Amid-Makrozyklen V |
GB0609492D0 (en) | 2006-05-15 | 2006-06-21 | Angeletti P Ist Richerche Bio | Therapeutic agents |
WO2008095999A1 (fr) | 2007-02-08 | 2008-08-14 | Tibotec Pharmaceuticals Ltd. | Inhibiteurs macrocycliques du virus de l'hépatite c (vhc) substitués par pyrimidine |
US20090275519A1 (en) | 2008-02-08 | 2009-11-05 | Aileron Therapeutics, Inc. | Therapeutic peptidomimetic macrocycles |
EP2350031A2 (fr) | 2008-08-20 | 2011-08-03 | Ensemble Therapeutics Corporation | Composés destinés à l inhibition du facteur de nécrose tumorale alpha |
US20120270807A1 (en) | 2009-10-23 | 2012-10-25 | Marsault Eric | Macrocyclic inhibitors of serine protease enzymes |
US20110105389A1 (en) | 2009-10-30 | 2011-05-05 | Hoveyda Hamid R | Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same |
ES2711526T3 (es) | 2010-08-13 | 2019-05-06 | Aileron Therapeutics Inc | Macrociclos peptidomiméticos |
EP3041491A1 (fr) | 2011-08-31 | 2016-07-13 | New York University | Peptidomimétiques contenant des succédanés à liaison hydrogène associée à un thioéther, un éther et une alkylamine |
MX362492B (es) | 2012-02-15 | 2019-01-21 | Aileron Therapeutics Inc | Macrociclos peptidomiméticos. |
CN103387601B (zh) | 2012-05-11 | 2017-01-11 | 南开大学 | 抗登革热病毒(denv)杂环肽类化合物及其制备方法和用途 |
WO2014048976A1 (fr) * | 2012-09-25 | 2014-04-03 | Vaxdyn Sl | Immunogènes anti-acinetobacter baumannii |
MX2015006340A (es) | 2012-11-21 | 2015-09-07 | Rqx Pharmaceuticals Inc | Antibioticos macrociclicos de amplio espectro. |
US9493510B2 (en) | 2013-01-10 | 2016-11-15 | Noliva Therapeutics Llc | Peptidomimetic compounds |
EP2942389A1 (fr) * | 2014-05-05 | 2015-11-11 | Servicio Andaluz De Salud | Vaccin contre Acinetobacter baumannii basé sur composants cellulaires deficients en lipopolysaccharides |
JP2017523197A (ja) | 2014-07-30 | 2017-08-17 | エービーエーシー セラピューティクス,エス.エル. | 2−ピリドン部分を含む選択的抗菌剤としてのアリールヒドラジド |
DK3368544T3 (da) | 2015-10-27 | 2020-08-24 | Hoffmann La Roche | Peptidmakrocykler mod Acinetobacter baumannii |
EP3388444A1 (fr) | 2017-04-10 | 2018-10-17 | F. Hoffmann-La Roche AG | Macrocycles peptidiques antibactériens et utilisation associée |
US11505573B2 (en) | 2018-03-28 | 2022-11-22 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
US11819532B2 (en) * | 2018-04-23 | 2023-11-21 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
-
2019
- 2019-04-19 US US16/389,292 patent/US11819532B2/en active Active
- 2019-04-22 TW TW108113979A patent/TWI833748B/zh active
- 2019-04-23 AU AU2019260124A patent/AU2019260124A1/en active Pending
- 2019-04-23 EP EP19719814.6A patent/EP3784262A1/fr active Pending
- 2019-04-23 PE PE2020000996A patent/PE20210855A1/es unknown
- 2019-04-23 MX MX2020007633A patent/MX2020007633A/es unknown
- 2019-04-23 BR BR112020021729-8A patent/BR112020021729A2/pt unknown
- 2019-04-23 MA MA052352A patent/MA52352A/fr unknown
- 2019-04-23 SG SG11202007219PA patent/SG11202007219PA/en unknown
- 2019-04-23 JP JP2020558432A patent/JP7460541B2/ja active Active
- 2019-04-23 IL IL309537A patent/IL309537A/en unknown
- 2019-04-23 CN CN201980020627.4A patent/CN111886020B/zh active Active
- 2019-04-23 CA CA3089688A patent/CA3089688A1/fr active Pending
- 2019-04-23 IL IL278053A patent/IL278053B2/en unknown
- 2019-04-23 KR KR1020207029322A patent/KR20210005574A/ko unknown
- 2019-04-23 CR CR20200488A patent/CR20200488A/es unknown
- 2019-04-23 UA UAA202007319A patent/UA126943C2/uk unknown
- 2019-04-23 WO PCT/EP2019/060272 patent/WO2019206853A1/fr active Application Filing
- 2019-04-23 AR ARP190101064A patent/AR114290A1/es unknown
-
2020
- 2020-10-16 CL CL2020002695A patent/CL2020002695A1/es unknown
- 2020-10-23 PH PH12020551762A patent/PH12020551762A1/en unknown
-
2023
- 2023-10-12 US US18/379,626 patent/US20240050516A1/en active Pending
-
2024
- 2024-01-26 JP JP2024010026A patent/JP2024050700A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20210005574A (ko) | 2021-01-14 |
UA126943C2 (uk) | 2023-02-22 |
JP2024050700A (ja) | 2024-04-10 |
CR20200488A (es) | 2021-02-26 |
TW201945386A (zh) | 2019-12-01 |
AR114290A1 (es) | 2020-08-12 |
JP2021522210A (ja) | 2021-08-30 |
TWI833748B (zh) | 2024-03-01 |
US11819532B2 (en) | 2023-11-21 |
SG11202007219PA (en) | 2020-08-28 |
CN111886020B (zh) | 2024-04-05 |
IL278053A (en) | 2020-11-30 |
JP7460541B2 (ja) | 2024-04-02 |
PH12020551762A1 (en) | 2021-06-14 |
US20240050516A1 (en) | 2024-02-15 |
PE20210855A1 (es) | 2021-05-18 |
BR112020021729A2 (pt) | 2021-01-26 |
EP3784262A1 (fr) | 2021-03-03 |
US20190321440A1 (en) | 2019-10-24 |
MX2020007633A (es) | 2020-09-14 |
CL2020002695A1 (es) | 2021-02-19 |
IL309537A (en) | 2024-02-01 |
IL278053B1 (en) | 2024-01-01 |
IL278053B2 (en) | 2024-05-01 |
CN111886020A (zh) | 2020-11-03 |
CA3089688A1 (fr) | 2019-10-31 |
WO2019206853A1 (fr) | 2019-10-31 |
AU2019260124A1 (en) | 2020-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA52352A (fr) | Macrocycles peptidiques contre acinetobacter baumannii | |
HK1258443A1 (zh) | 對抗鮑曼不動桿菌(acinetobacter baumannii)的肽大環 | |
PT3626699T (pt) | Inibidor de ssao | |
AU201815218S (en) | Chair | |
CA185967S (en) | Chair | |
CA184715S (en) | Chair | |
CA185323S (en) | Chair | |
AU201816222S (en) | Chair | |
AU201815210S (en) | Chair | |
AU201815213S (en) | Chair | |
CA188126S (en) | Stool | |
AU201813716S (en) | Chair | |
CA184766S (en) | Chair | |
NO20180039A1 (en) | Foldable chair | |
AU201713805S (en) | Beach Chair | |
PL3857661T3 (pl) | Autotest AFCI | |
CA184789S (en) | Walk-in bathtub | |
CA184788S (en) | Walk-in bathtub | |
CA185243S (en) | Chair | |
CA185244S (en) | Chair | |
PL3664672T3 (pl) | Przenośna toaleta | |
ZA201708653B (en) | Peptide macrocycles against acinetobacter baumannii | |
LT3368544T (lt) | Peptidų makrociklai prieš acinetobacter baumannii | |
CA192363S (en) | Portable toilet | |
GB201801042D0 (en) | Stool |